{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T09:16:30Z","timestamp":1781082990658,"version":"3.54.1"},"reference-count":73,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Faculty of Pharmacy and Pharmaceutical Sciences, Monash University"},{"name":"Mei Khoo (Monash)"},{"name":"Chau Nguyen (Swinburne)"},{"name":"Walaa Aburayan, Chau Nguyen and Edmond Linossi (Swinburne)"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.ijpharm.2017.06.040","type":"journal-article","created":{"date-parts":[[2017,6,13]],"date-time":"2017-06-13T14:16:02Z","timestamp":1497363362000},"page":"524-535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["The role of lecithin degradation on the pH dependent stability of halofantrine encapsulated fat nano-emulsions"],"prefix":"10.1016","volume":"528","author":[{"given":"Iman","family":"Haidar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian H.","family":"Harding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian C.","family":"Bowater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Eldridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William N.","family":"Charman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2017.06.040_bib0005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/10601339909040321","article-title":"Absolute bioavailability of halofantrine-HCl: effect of ranitidine and pentagastrin treatment","volume":"16","author":"Ajayi","year":"1999","journal-title":"Clin. Res. Regul. Aff."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0010","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ijpharm.2016.04.070","article-title":"Comparison of pharmaceutical nanoformulations for curcumin: enhancement of aqueous solubility and carrier retention","volume":"506","author":"Allijn","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0015","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1995-7645(11)60081-3","article-title":"In vitro properties of surface-modified solid lipid microspheres containing an antimalarial drug: halofantrine","volume":"4","author":"Attama","year":"2011","journal-title":"Asian Pac. J. Trop. Med."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0020","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0163-7827(96)00001-X","article-title":"Phospholipid-rich particles in commercial parenteral fat emulsions: an overview","volume":"35","author":"Bach","year":"1996","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0025","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/ics.12108","article-title":"Physical and material properties of an emulsion-based lipstick produced via a continuous process","volume":"36","author":"Beri","year":"2014","journal-title":"Int. J. Cosmet. Sci."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0030","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1086\/424603","article-title":"Fosmidomycin-clindamycin for the treatment of Plasmodium falciparum malaria","volume":"190","author":"Borrmann","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0035","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0378-5173(82)90138-7","article-title":"Stability of a fat emulsion based intravenous-feeding mixture","volume":"13","author":"Burnham","year":"1982","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0040","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1002\/jps.23211","article-title":"Intravenous dosing conditions may affect systemic clearance for highly lipophilic drugs: implications for lymphatic transport and absolute bioavailability studies","volume":"101","author":"Caliph","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0045","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1002\/jps.23597","article-title":"The impact of lymphatic transport on the systemic disposition of lipophilic drugs","volume":"102","author":"Caliph","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0050","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1006\/jcis.1995.1408","article-title":"Electroacoustic determination of droplet size and zeta potential in concentrated intravenous fat emulsions","volume":"174","author":"Carasso","year":"1995","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0055","first-page":"54","article-title":"Emulsion preparation and stability","volume":"86","author":"Cavallo","year":"1990","journal-title":"Chem. Eng. Prog."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0060","unstructured":"Charman, W.N., Porter, C.J.H., 1999. Halofantrine free base for the treatment of malaria and compositions. US Patent 5,968,987."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0065","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1399-6576.1976.tb05033.x","article-title":"Diazepam in emulsion form for intravenous usage","volume":"20","author":"Dardel","year":"1976","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0070","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ejpb.2016.08.001","article-title":"Preclinical safety of solid lipid nanoparticles and nanostructured lipid carriers: current evidence from in vitro and in vivo evaluation","volume":"108","author":"Doktorovova","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0075","first-page":"236","article-title":"Evaluation of physical stability of all in one parenteral admixtures for pediatric home care with high electrolytes concentrations","volume":"31","author":"Dorota","year":"2015","journal-title":"Nutr. Hosp. J."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0080","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1007\/s11095-006-9092-4","article-title":"Lipid injectable emulsions: pharmacopeial and safety issues","volume":"23","author":"Driscoll","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0085","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/BFb0118524","article-title":"Murphy\u2019s law of particle sizing: comparison of the size distributions of lecithin liposomes obtained by dynamic light scattering and electron microscopy","volume":"93","author":"Egelhaaf","year":"1993","journal-title":"Prog. Colloid Polym. Sci."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0090","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/tropej\/fmh069","article-title":"A randomized open label clinical trial to compare the efficacy and safety of intravenous quinine followed by oral malarone vs. intravenous quinine followed by oral quinine in the treatment of severe malaria","volume":"51","author":"Esamai","year":"2005","journal-title":"J. Trop. Pediatr."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0095","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1517\/17425247.4.4.403","article-title":"Drug delivery strategies for poorly water-soluble drugs","volume":"4","author":"Fahr","year":"2007","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0100","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0899-9007(01)00667-0","article-title":"Intralipid 10%: physicochemical characterization","volume":"17","author":"Ferezou","year":"2001","journal-title":"Nutrition"},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0105","doi-asserted-by":"crossref","DOI":"10.1016\/0140-6736(90)92884-K","article-title":"Cross-resistance between mefloquine and halofantrine","volume":"336","author":"Gay","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0110","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.molbiopara.2007.01.005","article-title":"The effects of anti-bacterials on the malaria parasite Plasmodium falciparum","volume":"152","author":"Goodman","year":"2007","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0115","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0005-2760(93)90216-V","article-title":"The effect of surface charge on the hydrolysis kinetics of partially hydrogenated egg phosphatidylcholine and egg phosphatidylgycerol in aqueous liposome dispersions","volume":"1167","author":"Grit","year":"1993","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0120","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijantimicag.2009.02.024","article-title":"Nanoencapsulation increases quinine antimalarial efficacy against Plasmodium berghei in vivo","volume":"34","author":"Haas","year":"2009","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0125","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ijpharm.2004.10.002","article-title":"Partition of antimicrobial additives in an intravenous emulsion and their effect on emulsion physical stability","volume":"288","author":"Han","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0130","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0378-5173(00)00692-X","article-title":"Physical properties and stability of two emulsion formulations of propofol","volume":"215","author":"Han","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0135","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3109\/15563650.2016.1151528","article-title":"Systematic review of clinical adverse events reported after acute intravenous lipid emulsion administration","volume":"54","author":"Hayes","year":"2016","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0140","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1023\/A:1018932421357","article-title":"The influence of free fatty acid formation on the pH of phospholipid-stabilized triglyceride emulsions","volume":"10","author":"Herman","year":"1993","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0145","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ejps.2011.01.007","article-title":"A novel excipient, 1-perfluorohexyloctane shows limited utility for the oral delivery of poorly water-soluble drugs","volume":"42","author":"Holm","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0150","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ejpb.2012.03.005","article-title":"Influence of bile on the absorption of halofantrine from lipid-based formulations","volume":"81","author":"Holm","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0155","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0169-409X(96)00494-2","article-title":"Lipid-based vehicles for the oral delivery of poorly water soluble drugs","volume":"25","author":"Humberstone","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0160","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0731-7085(95)01256-K","article-title":"Simplified liquid-chromatography assay for the quantitation of halofantrine and desbutylhalofantrine in plasma and identification of a degradation product of desbutylhalofantrine formed under alkaline conditions","volume":"13","author":"Humberstone","year":"1995","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0165","doi-asserted-by":"crossref","first-page":"15503","DOI":"10.1021\/jp960758y","article-title":"Effects of dissolved gas on emulsions, emulsion polymerization and surfactant aggregation","volume":"100","author":"Karaman","year":"1996","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0170","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0378-5173(98)00054-4","article-title":"Formulation design and bioavailability assessment of lipoic self-emulsifying formulations of halofantrine","volume":"167","author":"Khoo","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0175","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0378-5173(00)00485-3","article-title":"The formulation of halofantrine as either non-solubilising PEG 6000 or solubilising lipid based solid dispersions: physical stability and absolute bioavailability assessment","volume":"205","author":"Khoo","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0180","series-title":"Zeta for Windows","author":"Kosmulski","year":"2002"},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0185","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2125.1993.tb00419.x","article-title":"Pharmacokinetics, efficacy and toxicity of parenteral halofantrine in uncomplicated malaria","volume":"36","author":"Krishna","year":"1993","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0190","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/0021-9797(90)90390-A","article-title":"Three-phase behavior and HLB numbers of bile salts and lecithin in a water-oil system","volume":"136","author":"Kunieda","year":"1990","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0195","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0005-2736(95)00037-4","article-title":"Interaction of free fatty acids with phospholipid bilayers","volume":"1236","author":"Langner","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0200","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1177\/009127002401382632","article-title":"Interaction trial between artemether-lumefantrine (Riamet (R)) and quinine in healthy subjects","volume":"42","author":"Lefevre","year":"2002","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0205","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.lfs.2006.12.019","article-title":"Cardiotoxicity reduction induced by halofantrine entrapped in nanocapsule devices","volume":"80","author":"Leite","year":"2007","journal-title":"Life Sci. J."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0210","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1128\/AAC.46.8.2315-2320.2002","article-title":"Clindamycin as an antimalarial drug: review of clinical trials","volume":"46","author":"Lell","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0215","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1002\/jps.2600831114","article-title":"Structural studies of commercial fat emulsions used in parenteral nutrition","volume":"83","author":"Li","year":"1994","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0220","first-page":"28","article-title":"Using a microfluidizer to manufacture parenteral emulsions","author":"Lidgate","year":"1989","journal-title":"Biophys. J ."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0225","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.foodchem.2012.12.046","article-title":"Phospholipids in rice: significance in grain quality and health benefits: a review","volume":"139","author":"Liu","year":"2013","journal-title":"Food Chem."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0230","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1002\/jps.23711","article-title":"Formulation design and optimization for the improvement of nystatin-loaded lipid intravenous emulsion","volume":"102","author":"Marin-Quintero","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0235","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1211\/0022357022520","article-title":"Evaluation of the impact of altered lipoprotein binding conditions on halofantrine induced QTc interval prolongation in an anaesthetized rabbit model","volume":"56","author":"McIntosh","year":"2004","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0240","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1166\/jnn.2006.444","article-title":"Surface-modified and conventional nanocapsules as novel, formulations for parenteral delivery of halofantrine","volume":"6","author":"Mosqueira","year":"2006","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0245","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ijpharm.2003.09.019","article-title":"SolEmuls (R) \u2013 novel technology for the formulation of i.v: emulsions with poorly soluble drugs","volume":"269","author":"Muller","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0250","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.2174\/1381612822666160603014511","article-title":"Exploring nanotechnologies for the effective therapy of malaria using plant-based medicines","volume":"22","author":"Oga","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0255","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3109\/10837450.2014.949270","article-title":"Formulation, in vitro and in vivo evaluation of halofantrine-loaded solid lipid microparticles","volume":"20","author":"Ogbonna","year":"2015","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0260","first-page":"234","article-title":"The effect of surfactants on Van der Waals forces at a solid-liquid interface","volume":"1","author":"Padday","year":"1969","journal-title":"Surface Colloid Science"},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0265","doi-asserted-by":"crossref","first-page":"11767","DOI":"10.3390\/ijms140611767","article-title":"Phospholipids at the interface: current trends and challenges","volume":"14","author":"Pichot","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0270","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.arcped.2013.08.002","article-title":"Treatment of severe and uncomplicated falciparum malaria in children in France","volume":"20","author":"Pull","year":"2013","journal-title":"Arch. Pediatr."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0275","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0005-2760(91)90169-I","article-title":"Physico-chemical charcterization of intralipidTM Emulsions","volume":"1086","author":"Rotenberg","year":"1991","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0280","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ijpharm.2014.06.024","article-title":"A continuous flow method for estimation of drug release rates from emulsion formulations","volume":"472","author":"Salmela","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0285","first-page":"59","article-title":"Optimisation and stability assessment of solid lipid nanoparticles using particle size and zeta potential","volume":"25","author":"Shah","year":"2014","journal-title":"J. Phys. Sci."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0290","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jcis.2014.04.057","article-title":"Physicochemical characterization of solid lipid nanoparticles (SLNs) prepared by a novel microemulsion technique","volume":"428","author":"Shah","year":"2014","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0295","series-title":"Lipid Nanoparticles: Production, Characterization and Stability","author":"Shah","year":"2015"},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0300","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ijpharm.2016.10.054","article-title":"Microwave-assisted formulation of solid lipid nanoparticles loaded with non-steroidal anti-inflammatory drugs","volume":"515","author":"Shah","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0305","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.apmt.2016.09.010","article-title":"Encapsulation of clotrimazole into solid lipid nanoparticles by microwave-assisted microemulsion technique","volume":"5","author":"Shah","year":"2016","journal-title":"Appl. Mater. Today"},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0310","first-page":"18","article-title":"Development and evaluation of a test program for Y-site compatibility testing of total parenteral nutrition and intravenous drugs","volume":"15","author":"Staven","year":"2016","journal-title":"Nutr. J."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0315","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.memsci.2012.12.013","article-title":"Geometric parameters influencing production of O\/W\/emulsions using flat metallic membranes and scale-up","volume":"430","author":"Suarez","year":"2013","journal-title":"J. Membr. Sci."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0320","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1002\/jps.10479","article-title":"Partitioning of halofantrine hydrochloride between water, micellar solutions, and oil: effects on its apparent ionization constant","volume":"92","author":"Taillardat-Bertschinger","year":"2003","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0325","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jconrel.2012.02.027","article-title":"In vitro and in vivo performance of novel supersaturated self-nanoemulsifying drug delivery systems (super-SNEDDS)","volume":"160","author":"Thomas","year":"2012","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0330","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0006-3495(86)83655-4","article-title":"The intrinsic pKa values for phosphatidylserine and phosphatidylethanolamine in phosphatidylcholine host bilayers","volume":"49","author":"Tsu","year":"1986","journal-title":"Biophys. J."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0335","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.patbio.2007.09.003","article-title":"Tolerance and efficacy of mefloquine as the first line treatment of uncomplicated P-falciparum malaria in children","volume":"56","author":"Valeyre","year":"2008","journal-title":"Pathol. Biol."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0340","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0378-5173(87)90195-5","article-title":"Ageing effects in parenteral fat emulsions: the role of fatty acids","volume":"39","author":"Washington","year":"1987","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0345","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0378-5173(89)90096-3","article-title":"The electrokinetic properties of phospholipid-stabilized fat emulsions","volume":"54","author":"Washington","year":"1989","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0350","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2710.1993.tb00578.x","article-title":"Physicochemical properties of parenteral fat emulsions containing 20% triglyceride; intralipid and ivelip","volume":"18","author":"Washington","year":"1993","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0378-5173(90)90379-I","article-title":"The stability of intravenous fat emulsions in total parenteral nutrition mixtures","volume":"66","author":"Washington","year":"1990","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0360","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0378-5173(92)90240-3","article-title":"The electrokinetic properties of phospholipid stabilized fat emulsions. VI: Zeta potentials of Intralipid 20% in TPN mixtures","volume":"87","author":"Washington","year":"1992","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.06.040_bib0365","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1007\/s00018-006-6071-1","article-title":"Antimalarial drugs: recent advances in molecular determinants of resistance and their clinical significance","volume":"63","author":"Woodrow","year":"2006","journal-title":"Cell. Mol. Life Sci."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517317305483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517317305483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T18:55:17Z","timestamp":1535741717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517317305483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":73,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0378517317305483"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2017.06.040","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of lecithin degradation on the pH dependent stability of halofantrine encapsulated fat nano-emulsions","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2017.06.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}